These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23601709)

  • 1. Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors.
    Wang C; Moseley CK; Carlin SM; Wilson CM; Neelamegam R; Hooker JM
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3389-92. PubMed ID: 23601709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vivo evaluation of [11C]MPTQ: a potential PET tracer for alpha2A-adrenergic receptors.
    Prabhakaran J; Majo VJ; Milak MS; Mali P; Savenkova L; Mann JJ; Parsey RV; Kumar JS
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3654-7. PubMed ID: 20529687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosynthesis of [11C]BBAC and [11C]BBPC as potential PET tracers for orexin2 receptors.
    Liu F; Majo VJ; Prabhakaran J; Castrillion J; Mann JJ; Martinez D; Kumar JS
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2172-4. PubMed ID: 22364813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
    Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
    Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA.
    Suno R; Kimura KT; Nakane T; Yamashita K; Wang J; Fujiwara T; Yamanaka Y; Im D; Horita S; Tsujimoto H; Tawaramoto MS; Hirokawa T; Nango E; Tono K; Kameshima T; Hatsui T; Joti Y; Yabashi M; Shimamoto K; Yamamoto M; Rosenbaum DM; Iwata S; Shimamura T; Kobayashi T
    Structure; 2018 Jan; 26(1):7-19.e5. PubMed ID: 29225076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors.
    Liu F; Majo VJ; Prabhakaran J; Milak MS; John Mann J; Parsey RV; Kumar JS
    Bioorg Med Chem; 2011 Sep; 19(17):5255-9. PubMed ID: 21821420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro and in vivo evaluation of [11C]MMTP: a potential PET ligand for mGluR1 receptors.
    Prabhakaran J; Majo VJ; Milak MS; Kassir SA; Palner M; Savenkova L; Mali P; Arango V; Mann JJ; Parsey RV; Kumar JS
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3499-501. PubMed ID: 20494576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of [(11)C]MK-1064 as a new PET radioligand for imaging of orexin-2 receptor.
    Gao M; Wang M; Zheng QH
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3694-9. PubMed ID: 27268698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosynthesis and radiopharmacological evaluation of [N-methyl-11C]Org 34850 as a glucocorticoid receptor (GR)-binding radiotracer.
    Wuest F; Kniess T; Henry B; Peeters BW; Wiegerinck PH; Pietzsch J; Bergmann R
    Appl Radiat Isot; 2009 Feb; 67(2):308-12. PubMed ID: 19071028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
    Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
    Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.
    Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M
    Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.
    Turolla EA; Matarrese M; Belloli S; Moresco RM; Simonelli P; Todde S; Fazio F; Magni F; Kienle MG; Leopoldo M; Berardi F; Colabufo NA; Lacivita E; Perrone R
    J Med Chem; 2005 Nov; 48(22):7018-23. PubMed ID: 16250661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of potential PET imaging probes for the orexin 2 receptors.
    Wang C; Wilson CM; Moseley CK; Carlin SM; Hsu S; Arabasz G; Schroeder FA; Sander CY; Hooker JM
    Nucl Med Biol; 2013 Nov; 40(8):1000-5. PubMed ID: 23953751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
    Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
    Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
    de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
    J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
    Sobrio F; Quentin T; Dhilly M; Bourdier T; Tymciu S; Debruyne D; Barré L
    Nucl Med Biol; 2008 Apr; 35(3):377-85. PubMed ID: 18355694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors.
    Kumar JS; Majo VJ; Sullivan GM; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
    Bioorg Med Chem; 2006 Jun; 14(12):4029-34. PubMed ID: 16529935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
    Kumar JS; Prabhakaran J; Erlandsson K; Majo VJ; Simpson NR; Pratap M; Van Heertum RL; Mann JJ; Parsey RV
    Nucl Med Biol; 2006 May; 33(4):565-74. PubMed ID: 16720250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
    Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
    Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.